Univest
Univest
  • Markets

Poly Medicure Stock Prediction 2026: Expert Analysis, Forecast Scenarios and Full Stock Review

  • June 15, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Poly Medicure Stock Prediction 2026

Poly Medicure CMP: Rs 1,540 (2026). 52W High: Rs 2,318. 52W Low: Rs 1,182. Mkt Cap: Rs 15,620 Cr. P/E: 45.8. Analyst Consensus: Rs 1760.

The Poly Medicure stock prediction for 2026 from leading brokerages covers a range reflecting sector dynamics, earnings trajectory and the macro environment. All estimates may or may not be achieved. Treat any Poly Medicure share price prediction as one data point and not as a guarantee of future performance.

This article reviews every dimension of the Poly Medicure stock forecast analysts are tracking, including key drivers, bull and bear scenarios and the primary risks. Verify all figures with the latest brokerage reports before any investment decision.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • What Analysts Predict for Poly Medicure Stock in 2026
  • Poly Medicure Company Overview
  • Poly Medicure Stock Prediction by Time Horizon
    • Short-Term Poly Medicure Stock Prediction
    • 12-Month Poly Medicure Stock Prediction
    • Long-Term Poly Medicure Stock Prediction
  • Poly Medicure Stock Forecast: Key Factors
    • Bed Addition and Occupancy
    • Revenue per Occupied Bed
    • EBITDA Margin Maturity
    • International Patient Revenue
  • Poly Medicure Stock Prediction: Bull and Bear Scenarios
  • How Analysts Are Reading the Poly Medicure Stock Story
  • Key Risks to the Poly Medicure Stock Prediction
    • New Hospital Ramp-Up Costs
    • Regulatory and Price Cap Risk
    • Competition
    • Medical Cost Inflation
  • How to Monitor the Poly Medicure Stock Forecast
  • Conclusion
  • Frequently Asked Questions on Poly Medicure Stock Prediction 2026
    • What is the Poly Medicure stock prediction for 2026?
    • Is the Poly Medicure stock prediction bullish or bearish?
    • What is the Poly Medicure share price prediction based on fundamentals?
    • What is the long-term Poly Medicure stock prediction?
    • What are the key risks to the Poly Medicure stock prediction?
    • What does the Poly Medicure stock forecast say for 2026?
    • Where can I track the latest Poly Medicure stock prediction?

What Analysts Predict for Poly Medicure Stock in 2026

Analyst consensus on the Poly Medicure stock prediction for 2026 is tracked by leading brokerages. The table below shows the latest available data from JM Financial and ICICI Securities. All figures are sourced from publicly available research and should be verified before publishing.

Brokerage Rating Poly Medicure Stock Prediction (Rs) Updated
JM Financial Buy Rs 1800 2026
ICICI Securities Buy Rs 1720 2026
Analyst Consensus — Rs 1760 2026

The Poly Medicure stock prediction range reflects genuine difference of opinion on demand recovery, margin trajectory and sector headwinds. The implied upside in the Poly Medicure stock forecast from the current price of Rs 1,540 may or may not be realised by end of 2026.

3 Stocks Building Serious Momentum Right Now

When Univest analysts identify high-conviction stock opportunities, investors pay attention.

Our research team has shortlisted the Top Stocks to Buy based on current market momentum, sector trends & growth potential for 2026.

  • Discover stocks investors are actively accumulating
  • High-conviction opportunities backed by research
  • Designed for the next phase of market growth

Unlock the latest Top Stock Picks now on Univest

See the Stocks →

Poly Medicure Company Overview

Poly Medicure is a leading healthcare services provider operating hospitals, diagnostics or specialty facilities across India. The Poly Medicure stock prediction for 2026 reflects structural growth in healthcare demand and operating leverage from bed expansion.

Metric Value
NSE Ticker POLYMED
Sector Healthcare Services and Hospitals
CMP Rs 1,540 (2026)
52 Week High Rs 2,318
52 Week Low Rs 1,182
Market Cap Rs 15,620 Cr
P/E Ratio 45.8
Poly Medicure Stock Prediction Consensus (12M) Rs 1760

Poly Medicure Stock Prediction by Time Horizon

Analysts split the Poly Medicure share price prediction across time frames as near-term drivers differ materially from the long-term view.

Short-Term Poly Medicure Stock Prediction

The near-term Poly Medicure stock forecast reflects current sentiment, sector news and upcoming earnings prints. Key support and resistance levels around Rs 1,540 are being watched closely. A short-term Poly Medicure share price prediction carries the most uncertainty of any time horizon.

12-Month Poly Medicure Stock Prediction

JM Financial targets Rs 1800 (Buy) and ICICI Securities targets Rs 1720 (Buy). Most desks refresh their Poly Medicure stock forecast within two to four weeks of each quarterly earnings print. The Poly Medicure share price prediction should be verified against the most recent analyst reports.

Long-Term Poly Medicure Stock Prediction

The long-term Poly Medicure stock prediction is built on assumptions about demand recovery, margin expansion and revenue diversification in the Healthcare Services and Hospitals sector. The long-term Poly Medicure share price prediction carries the most uncertainty and should be treated as directional guidance only.

Poly Medicure Stock Forecast: Key Factors

The following four factors appear consistently in research reports on the Poly Medicure stock prediction and are the primary inputs into the bull and bear case scenarios.

Bed Addition and Occupancy

Hospital bed additions and occupancy rates are the primary metrics in the Poly Medicure stock forecast. Analysts look for occupancy above 65 percent as the basis for a higher Poly Medicure share price prediction.

Revenue per Occupied Bed

Revenue per occupied bed improvement reflects the shift to higher-margin specialties. Analysts revise the Poly Medicure share price prediction upward when per-bed revenue grows consistently.

EBITDA Margin Maturity

A portfolio shift toward mature hospitals supports the bullish Poly Medicure stock prediction, while new hospital ramp-ups dilute margins in the near term.

International Patient Revenue

Medical tourism revenue provides premium pricing and diversifies the revenue base, supporting the Poly Medicure stock forecast and premium valuation.

Poly Medicure Stock Prediction: Bull and Bear Scenarios

Scenario Poly Medicure Stock Prediction Key Conditions
Bull Case Rs 1800 Strong execution, margin improvement, favourable macro and sector re-rating
Base Case Rs 1760 Steady performance, gradual recovery, margins hold, growth on track
Bear Case Rs 1182 Demand deterioration, margin pressure, sector de-rating and macro headwinds

The bull case Poly Medicure stock forecast of Rs 1800 assumes most positive variables converge. The base case of Rs 1760 is the analyst consensus and may or may not be achieved.

How Analysts Are Reading the Poly Medicure Stock Story

Analyst reviews of the Poly Medicure share price prediction highlight the company’s core strengths in Healthcare Services and Hospitals alongside near-term headwinds from macro uncertainty, competitive pressure and sector-level challenges. Overall the Poly Medicure stock prediction consensus is built on real business strengths set against real risks.

Key Risks to the Poly Medicure Stock Prediction

New Hospital Ramp-Up Costs

New hospital investments have multi-year ramp-up periods during which margins are diluted. This is a recurring near-term risk to the Poly Medicure stock prediction.

Regulatory and Price Cap Risk

Government-mandated price caps on medical procedures affect hospital revenues and can compress the Poly Medicure stock forecast.

Competition

New hospital chains expanding into metro and tier 2 cities create competitive pressure on occupancy and billing, which is a recurring caution in the Poly Medicure share price prediction.

Medical Cost Inflation

Rising manpower and consumables costs affect EBITDA margins and the Poly Medicure stock forecast. Cost risk is reflected in the width of the Poly Medicure share price prediction range.

How to Monitor the Poly Medicure Stock Forecast

Track the Poly Medicure share price prediction consensus quarterly. After every earnings release, most brokerages revise their Poly Medicure stock forecast within two weeks. Comparing the revised Poly Medicure stock prediction to the previous estimate tells you whether analyst sentiment is improving or deteriorating.

Compare the current price of Rs 1,540 with the analyst target range of Rs 1800 to Rs 1720. A wide Poly Medicure stock prediction band reflects genuine uncertainty, so position size should reflect that range rather than the midpoint alone.

Review the Poly Medicure share price prediction every quarter against key business metrics for the Healthcare Services and Hospitals sector. A single estimate from any analyst is a point-in-time view and should be treated as one input among many when making any investment decision.

Check Live Poly Medicure Fundamentals on the Univest Screener

Conclusion

The Poly Medicure stock prediction for 2026 reflects the analyst community’s assessment of Poly Medicure’s competitive position, earnings trajectory and macro environment. JM Financial holds a Buy stance with a target of Rs 1800 while ICICI Securities has a Buy rating with a target of Rs 1720, giving an analyst consensus of Rs 1760.

The Poly Medicure stock forecast is set against near-term risks that make the Poly Medicure share price prediction range wide. Investors should verify any estimate with the latest brokerage reports before using it as an investment reference. The analyst forecast will be revised after every quarterly result, so tracking changes in the Poly Medicure stock prediction over time is more valuable than relying on any single estimate.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.

Download the Univest iOS App or Univest Android App to track the live Poly Medicure stock prediction and share price prediction changes in real time.

Disclaimer: Data and figures in this article are sourced from publicly available information and may or may not be accurate. Analyst price targets are from public brokerage reports and should be independently verified. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Poly Medicure Stock Prediction 2026

What is the Poly Medicure stock prediction for 2026?

Ans. The Poly Medicure stock prediction for 2026 is based on analyst consensus from JM Financial and ICICI Securities. The consensus target is Rs 1760. All estimates may or may not be achieved.

Is the Poly Medicure stock prediction bullish or bearish?

Ans. JM Financial has a Buy rating with target Rs 1800. ICICI Securities has a Buy rating with target Rs 1720. The Poly Medicure stock forecast reflects genuine analyst diversity of opinion.

What is the Poly Medicure share price prediction based on fundamentals?

Ans. The Poly Medicure share price prediction rests on the bed addition pipeline, occupancy trend, revenue per bed and EBITDA margin maturity. Analysts tracking Poly Medicure closely cite these as the primary drivers of the 2026 outlook.

What is the long-term Poly Medicure stock prediction?

Ans. The long-term Poly Medicure stock prediction assumes the company sustains its core business drivers over a multi-year horizon. The 12-month consensus of Rs 1760 is the nearest reliable anchor point.

What are the key risks to the Poly Medicure stock prediction?

Ans. The primary risks include sector-specific headwinds, macro uncertainty, regulatory changes and competitive pressure. Every Poly Medicure stock prediction should be read alongside its risk assumptions.

What does the Poly Medicure stock forecast say for 2026?

Ans. JM Financial: Buy target Rs 1800. ICICI Securities: Buy target Rs 1720. These Poly Medicure share price prediction estimates may or may not prove accurate.

Where can I track the latest Poly Medicure stock prediction?

Ans. Track the latest Poly Medicure stock prediction on the NSE and BSE websites and on the Univest app and screener for live price and updated analyst targets.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply